share_log

Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

Enliven Therapeutics | SC 13G:超过5%持股股东披露文件-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

美股SEC公告 ·  11/14 06:57
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息